Tag archive for ‘MPM’
Gil Tanenbaum On Saturday, January 3rd, 2015

Israeli-American Biomed Firm Chiasma Raises $33.8 Million to Continue Development of Oral Meds

Israeli biomed company Chiasma has raised $33.8 million out of a planned total $56.3 million round of fundraising. It plans to use the infusion of new capital to continue the development of its oral octreotide. MPM More...

Gali Weinreb On Wednesday, August 6th, 2014

Roche cancels $600 million Chiasma deal

  Chiasma: The product is good. This was a strategic decision by Roche to be less involved in hormone-based drugs. – Roche AG (SWX: ROG) has notified Israeli startup Chiasma that it has cancelled More...

Wordpress site Developed by Fixing WordPress Problems